Convatec partners with Tandem Diabetes Care on new infusion set for innovative new Tandem Mobi system

• Tandem Mobi is the world’s smallest durable insulin delivery system¹
• Convatec’s AutoSoft XC with 5” tubing approved on the United States market offers new option for patients to conveniently and discreetly wear Tandem Mobi Tandem Mobi is also compatible with all infusion sets distributed by Tandem Diabetes Care to provide greater choice for people living with diabetes
• Partnership further demonstrates Convatec’s leadership in Infusion Care technology²
• Convatec is proud to be the supplier of infusion sets to Tandem Diabetes Care

Convatec Group Plc (LSE:CTEC), a FTSE 100 global medical products and technologies company focused on solutions for the management of chronic conditions, is pleased to announce its collaboration with Tandem Diabetes Care on a new five-inch infusion set  for Tandem Mobi, the world’s smallest durable automated insulin delivery system that has now been FDA 510(k) cleared³. Convatec is the global leader² in design and manufacturing of infusion technologies and insertion devices for insulin pump treatment.

Tandem Mobi is the latest insulin pump from Tandem Diabetes Care. The new insulin pump system aims to provide people living with diabetes with new options in wearability, the flexibility to disconnect, and full smartphone control. It has a 200-unit capacity, and is fully controllable from a mobile app. Tandem Mobi can fit in a coin pocket, be clipped to clothing, or worn on-body with an adhesive sleeve (sold separately by Tandem). 

 Specifically for Tandem Mobi, Convatec has developed the AutoSoft XC™ with a new 5” (12 cm) tubing. This set is now the shortest tubing provided by Convatec, enabling users to wear the pump as an on-body system providing both discretion but also flexibility.

 Convatec is pleased to manufacture the infusion sets for the insulin pumps in the Tandem product portfolio, including the currently available t:slim X2 insulin pump. Tandem infusion set options include AutoSoft XC™, AutoSoft 90™, AutoSoft 30™, VariSoft™ and TruSteel™. which allow users to temporarily disconnect from their pump for convenience and provide the flexibility of more than 30 mix-and-match infusion site and tubing length combinations, depending on their lifestyles and wear preference. These infusion sets use a kink-resistant⁴ infusion tubing, supporting an uninterrupted insulin infusion. Convatec manufactures these sets at our production sites in Mexico.

Kjersti Grimsrud, President & Chief Operating Officer, Infusion Care said, “We are pleased to continue working with Tandem with whom we have had a longstanding partnership. This partnership further demonstrates Convatec’s leadership in infusion technology and the trust from our partners to collaborate on innovative technology to improve the quality of life of people with diabetes.”

Contacts

About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence care and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more about Convatec, please visit http://www.convatecgroup.com

 About Tandem Diabetes Care
Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit http://www.tandemdiabetes.com

 Indications for Use
Tandem Mobi insulin pump: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices.

The pump is intended for single patient, home use and requires a prescription.
The pump is indicated for use in individuals six years of age and greater.

 ¹ As of July 2023. Data on file, Tandem Diabetes Care
² Seagrove SIMM GloveView April 2023
³https://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-mobi-worlds-smallest-durable-insulin-delivery-system
⁴ Convatec Data on File, Unomedical A/S. (D012-002912, D012-002950)

 © 2023 Convatec
AutoSoft XC, AutoSoft 90, AutoSoft 30, VariSoft and TruSteel are trademarks of Tandem Diabetes AP-63828-GBL-ENGU-v1 (v1.1)

 © 2023 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. All third-party marks are the property of their respective owners.